Show simple item record

 
dc.contributorIDIAP Jordi Gol
dc.contributor.authorCastellsagué, Jordi
dc.contributor.authorJacquot, Emmanuelle
dc.contributor.authorPladevall-Vila, Manel
dc.contributor.authorMorros, Rosa
dc.contributor.authorGiner-Soriano, Maria
dc.contributor.authorForns, Joan
dc.contributor.authorPottegård, Anton
dc.contributor.authorPoblador-Plou, Beatriz
dc.contributor.authorCainzos-Achirica, Miguel
dc.contributor.authorHellfritzsch, Maja
dc.contributor.authorPrados-Torres, Alexandra
dc.contributor.authorHallas, Jesper
dc.contributor.authorCortés, Jordi
dc.contributor.authorDeltour, Nicolas
dc.contributor.authorPerez-Gutthann, Susana
dc.date.accessioned2019-06-11T08:14:52Z
dc.date.available2019-06-11T08:14:52Z
dc.date.issued2019-06-06
dc.identifier.citationForns J, Cainzos-Achirica M, Hellfritzsch M, Morros R, Poblador-Plou B, Giner-Soriano M, et al. Validity of ICD-9 and ICD-10 codes used to identify acute liver injury: A study in three European data sources. Pharmacoepidemiol Drug Saf. 2019.
dc.identifier.issn1099-1557
dc.identifier.urihttps://hdl.handle.net/11351/4127
dc.descriptionAcute liver injury; Antidepressants; Pharmacoepidemiology
dc.description.abstractPURPOSE: Validating cases of acute liver injury (ALI) in health care data sources is challenging. Previous validation studies reported low positive predictive values (PPVs). METHODS: Case validation was undertaken in a study conducted from 2009 to 2014 assessing the risk of ALI in antidepressants users in databases in Spain (EpiChron and SIDIAP) and the Danish National Health Registers. Three ALI definitions were evaluated: primary (specific hospital discharge codes), secondary (specific and nonspecific hospital discharge codes), and tertiary (specific and nonspecific hospital and outpatient codes). The validation included review of patient profiles (EpiChron and SIDIAP) and of clinical data from medical records (EpiChron and Denmark). ALI cases were confirmed when liver enzyme values met a definition by an international working group. RESULTS: Overall PPVs (95% CIs) for the study ALI definitions were, for the primary ALI definition, 84% (60%-97%) (EpiChron), 60% (26%-88%) (SIDIAP), and 74% (60%-85%) (Denmark); for the secondary ALI definition, 65% (45%-81%) (EpiChron), 40% (19%-64%) (SIDIAP), and 70% (64%-77%) (Denmark); and for the tertiary ALI definition, 25% (18%-34%) (EpiChron), 8% (7%-9%) (SIDIAP), and 47% (42%-52%) (Denmark). The overall PPVs were higher for specific than for nonspecific codes and for hospital discharge than for outpatient codes. The nonspecific code "unspecified jaundice" had high PPVs in Denmark. CONCLUSIONS: PPVs obtained apply to patients using antidepressants without preexisting liver disease or ALI risk factors. To maximize validity, studies on ALI should prioritize hospital specific discharge codes and should include hospital codes for unspecified jaundice. Case validation is required when ALI outpatient cases are considered.
dc.language.isoeng
dc.publisherWiley Online Library
dc.relation.ispartofseriesPharmacoepidemiology and Drug Safety;
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectFarmacoepidemiologia
dc.subjectAntidepressius
dc.subjectRegistres mèdics
dc.subjectInsuficiència hepàtica - Diagnòstic
dc.subject.meshInternational Classification of Diseases
dc.subject.mesh/utilization
dc.subject.meshLiver Failure, Acute
dc.subject.meshAntidepressive Agents
dc.subject.meshPharmacoepidemiology
dc.titleValidity of ICD-9 and ICD-10 codes used to identify acute liver injury: A study in three European data sources
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1002/pds.4803
dc.subject.decsClasificación Internacional de Enfermedades
dc.subject.decs/utilización
dc.subject.decsfracaso hepático agudo
dc.subject.decsantidepresivos
dc.subject.decsfarmacoepidemiología
dc.relation.publishversionhttps://onlinelibrary.wiley.com/doi/full/10.1002/pds.4803
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Forns J, Cainzos-Achirica M, Castellsagué J, Perez-Gutthann S] Epidemiology, RTI Health Solutions, Barcelona, Spain. [Hellfritzsch M, Hallas J, Pottegård A] Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Odense, Denmark. [Morros R, Giner-Soriano M] Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès), Barcelona, Spain. Institut Català de la Salut, Barcelona, Spain. [Poblador-Plou B, Prados-Torres A] EpiChron, Instituto Aragonés de Ciencias de la Salud, (IACS), IIS Aragón, REDISSEC ISCIII, Zaragoza, Spain. [Cortés J] Departament d'Estadística i Investigació Operativa, Universitat Politècnica de Catalunya, Barcelona, Spain. [Jacquot E, Deltour N] Pharmacoepidemiology Department, Les Laboratoires Servier, Paris, France. [Pladevall M] Epidemiology, RTI Health Solutions, Barcelona, Spain. The Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit, MI, USA.
dc.identifier.pmid31172633
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record